In Vivo Oncology Tumor Models Services
MB Biosciences offers preclinical oncology models and services with client-specific customized study design. We offer human xenograft tumor models and syngeneic tumor models. Using those tumor models with appropriate translational tools, you can identify promising compounds and optimize lead candidates.
MB Biosciences Advantages
•Experienced and skilled team
•Quick turnaround time
•Offer in vivo proof-of-concept studies
•Customize tumor models of your interest
Xenograft tumor models are widely used for preclinical test to evaluate the efficacy of anti-tumor therapeutics and study the mechanisms of action in the biologic processes in oncology. Xenografts models are established by injection of tumor cell into immunodeficient mice. MB Biosciences offer a broad range of human tumor cell line-derived xenograft (CDX) models, orthotopic mouse model and patient-derived tumor xenografts mouse models.
Cancer immunotherapies are designed to cooperating with a patient's own immune system to increase native anti-tumor responses. Syngeneic mouse models provide an effective approach in studying how cancer therapies response in the presence of a functional immune system. MB Biosciences offers multiple syngeneic mouse models for your research on tumor drug discovery.
